Fairmont Hotels & Resorts today announced the signing of a new property in Agra, the city of the Taj Mahal, one of the seven wonders of the world and a UNESCO World Heritage Site. Set to open by 2025, the hotel will offer 205 rooms, including 44 suites. Guests can look forward to a luxurious experience that seamlessly blends world-class hospitality with the enchanting beauty of one of India's most legendary destinations.
Fairmont Hotels & Resorts has partnered with Shekhar Resorts Limited, introducing the first Fairmont in the city of Agra.
“We are delighted to partner with Fairmont, an iconic luxury brand within the Accor Group. Given Accor’s expertise in luxury hospitality management and knowledge of the markets they operate in, we found Fairmont and Accor as the most adept partners to manage the upcoming Fairmont Agra. We believe that the property will stand out and elevate the luxury hospitality experience in Agra and northern India. We are excited to start our first partnership with Fairmont and Accor and to bring the most unique and memorable experiences to our guests,” says Anuj Jain, Director of Shekhar Resorts Limited, Agra.
Fairmont Agra's strategic location is approximately two kilometres from the Taj Mahal, offering guests easy access to this renowned architectural achievement. Situated on the banks of the Yamuna River in the populous city of Agra, located in the northern state of Uttar Pradesh, the hotel is just a two-hour drive from the bustling capital city of New Delhi.
“This is a great addition to our brand portfolio,” says Mark Willis, CEO of Fairmont Hotels & Resorts. “Fairmont Agra will be situated in one of the most awe-inspiring destinations in the world, and I am confident that its strategic location, architecture, and breathtaking views will make it one of our top iconic properties. With the brand's exceptional standards, Fairmont Agra is set to offer an unforgettable experience to its guests.”
Fairmont is one of Accor’s leading luxury brands globally, with more than a century of history, and landmark hotels positioned in extraordinary destinations worldwide – from The Plaza in New York City and The Savoy in London to Fairmont Peace Hotel in Shanghai and Fairmont Royal Palm in Marrakech. In India, Fairmont already operates the majestic Fairmont Jaipur and will open additional hotels in Udaipur, Mumbai and Shimla Fagu over the next two years.
Mark Willis adds: “Fairmont is gaining momentum in India, with four exciting new properties under development. With Agra on the horizon, the brand will complete India's northern Golden Triangle, alongside Jaipur and Udaipur.”
Fairmont properties around the globe are known for their luxurious guest rooms, world-class public spaces and dining venues, and amazing locations from which they provide guests with unforgettable memories – and Fairmont Agra will be no different. The property will offer sumptuously comfortable rooms alongside an array of offerings, including a signature restaurant, specialty restaurant, coffee shop, bar, swimming pool, fitness center and spa. Guests can expect a world-class experience that embodies the Fairmont brand's commitment to providing exceptional luxury and service.
Fairmont is part of Accor, a world leading hospitality group that offers experiences in over 110 countries and over 5,400 properties, making it one of the industry's most diverse hospitality ecosystems. The world’s second largest luxury and lifestyle operator, Accor’s portfolio includes more than 40 hotel brands that range from luxury to economy. Additionally, Fairmont is a participating brand in ALL - Accor Live Limitless, a lifestyle loyalty program that gives members access to a wide range of rewards, services, and experiences across Accor's vast network of hotels and resorts.
To know more, visit the website: fairmont.com
Fairmont Hotels and Resorts to Open New Property in Agra, the City of the Taj Mahal<br>

The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.More to Read
Fortis Inc. to Hold Teleconference and Webcast on November 3 to Discuss Third Quarter 2026 Results and New Five-Year Capital Outlook
ST. JOHN'S, Newfoundland and Labrador, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its third quarter 2026 financial results and new five-year capital outlook for the period 2027-2031 on Tuesday, November 3, 2026. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Co
ONEOK Schedules Third-Quarter 2026 Conference Call and Webcast
TULSA, Okla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- ONEOK, Inc. (NYSE: OKE) will release third-quarter 2026 earnings after the market closes on Oct. 27, 2026. Members of ONEOK’s management team will participate in a conference call the following day. What: ONEOK third-quarter 2026 earnings conference call and webcast When: Oct. 28, 2026, at 11 a.m. Eastern (10 a.m. Central) Where: 1) Conference call: Dial 800-330-6710 and use confirmation code: 5105567 2) Webcast: Join at www.oneok.com If you are un
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
BOSTON, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED (“ARCHIMED”), a leading investment firm focused exclusively on healthcare industries. Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools, said, “ARCHIMED brings deep healthcare and life sciences expertise, a strong understanding of the mark
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that it has commenced an underwritten public offering of its common stock. In addition, the Company is expected to grant th
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced the grant of inducement equity awards to four newly hired non-executive employees as a material inducement to commencing their employment with the Company. The equity awards were approved in accordance with Nasdaq Listing Rule
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
- October 6 YouTube premiere featuring Sway Calloway, Howard “H” White and leading medical and cultural voices anchors community education nationwide PALO ALTO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company” or “BridgeBio”), a commercial-stage, multi-product biopharmaceutical company focused on genetic diseases, today announced a nationwide education effort with community partners to increase awareness of transthyretin amyloid cardiomyopathy, also
PesoRama Announces C$25 Million Bought Deal Public Offering
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- PesoRama Inc. (TSXV:PESO) (OTC:PSSOF) (FSE:ZE6) (“ PesoRama ” or the “ Company ”), a Canadian company operating dollar stores in Mexico under the JOi DOLLAR PLUS brand, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter and sole bookrunner on behalf of itself and a syndicate of underwriters (collecti
Telos Secures $13.5 Million Contract to Continue Support of Air Force Intelligence Community Cyber Operations
Three-year award provides Xacta license maintenance, training and cyber services for Air Force ISR systems ASHBURN, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced it has been awarded a three-year, $13.5 million contract by the 16th Air Force to provide continued support for U.S. Air Force Intelligence, Surveillance and Reconnaissance
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!